(Q38662887)

5 September 2017

Cancer Genomics in Clinical Context (English)

1 reference

5 September 2017

1 reference

1

Lynda Chin

1 reference

5 September 2017

4

Hagop Kantarjian

1 reference

5 September 2017

5

P Andrew Futreal

1 reference

5 September 2017

2

Jennifer A Wargo

1 reference

5 September 2017

Denise J Spring

3

1 reference

5 September 2017

28 September 2015

1 reference

5 September 2017

1 reference

5 September 2017

1

1 reference

5 September 2017

1

1 reference

5 September 2017

36-43

1 reference

International network of cancer genome projects

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

An integrated encyclopedia of DNA elements in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Comprehensive molecular profiling of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Comprehensive molecular portraits of human breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Emerging patterns of somatic mutations in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Unraveling the clonal hierarchy of somatic genomic aberrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

A new initiative on precision medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

A functional landscape of resistance to ALK inhibition in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

A physical map of the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2015.07.010

10.1016/J.TRECAN.2015.07.010

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

28741560